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Summary 
Mutations in FUS gene cause familial amyotrophic lateral sclerosis (ALS-FUS). In ALS-FUS, 
FUS-positive inclusions are detected in the cytoplasm of neurons and glia – a condition 
known as FUS proteinopathy. Mutant FUS incorporates into stress granules (SGs) and can 
also spontaneously form cytoplasmic RNA granules in cultured cells. However it is still 
unclear what can trigger the persistence of mutant FUS assemblies and lead to inclusion 
formation. Using CRISPR/Cas9 cell lines and patient fibroblasts, we found that the “viral 
mimic” dsRNA poly(I:C) or a SG-inducing virus cause sustained presence of mutant FUS 
assemblies. These assemblies sequester the autophagy receptor optineurin and 
nucleocytoplasmic transport factors. Furthermore, an integral component of the antiviral 
immune response, type I interferon, promotes FUS protein accumulation by increasing FUS 
mRNA stability. Finally, mutant FUS expressing cells are hypersensitive to dsRNA toxicity. 
Our data suggest that the antiviral immune response is a plausible “second hit” for FUS 
proteinopathy. 
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Introduction 
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease. It is 
characterised by selective loss of upper and lower motor neurons in the central nervous 
system (CNS), which causes weakness and paralysis of the skeletal muscles they control 
(Peters et al., 2015). While the majority of ALS cases are sporadic (sALS), ~10% cases bear 
a familial component (familial, fALS). Mutations in more than 25 genes have been proven to 
cause the disease, with the FUS gene being one of the major fALS-causative genes 
(Kwiatkowski et al., 2009; Vance et al., 2009). 
FUS encodes a predominantly nuclear DNA/RNA binding protein with multiple functions in 
RNA metabolism (Ratti and Buratti, 2016). The majority of ALS-causative mutations affect 
the nuclear localisation signal (NLS) of FUS on its C-terminus thereby disrupting nuclear 
import of the protein and causing its cytoplasmic overabundance (Bosco et al., 2010; 
Dormann et al., 2010). Patients with ALS caused by FUS mutations (ALS-FUS) present with 
cytoplasmic FUS-positive inclusions in neurons and glia (Deng et al., 2014). Inclusions 
formed by non-mutated FUS protein are also found in the brain of some frontotemporal lobar 
degeneration (FTLD) patients (atypical FTLD-U subtype) (Neumann et al., 2009). Thus, 
conditions characterised by the presence of abnormal FUS inclusions are collectively 
referred to as “FUS proteinopathies”. 
Although FUS readily aggregates in the test tube, it is not the case in vivo, and available 
rodent models expressing mutant FUS do not develop FUS aggregates in the CNS (Devoy 
et al., 2017; Huang et al., 2011; Lopez-Erauskin et al., 2018; Scekic-Zahirovic et al., 2016; 
Sharma et al., 2016). Our own studies showed that in order to achieve efficient FUS 
aggregation in the murine nervous system, highly aggregate-prone artificial variants of FUS 
lacking RNA-binding domains have to be used (Robinson et al., 2015; Shelkovnikova et al., 
2013a). Yet, in FUS proteinopathies, full-length FUS or FUS with small C-terminal 
truncations forms cytoplasmic inclusions. This implies the requirement for an additional 
trigger that causes robust FUS aggregation and inclusion formation in human disease. 
Mutant FUS is characterised by a strong affinity to stress granules (SGs), a type of 
cytoplasmic stress-induced ribonucleoprotein (RNP) assembly (Bosco et al., 2010; Dormann 
et al., 2010). SGs have been heavily implicated in ALS pathogenesis since ALS-causative 
mutations affect not only FUS but also a number of other SG proteins (Li et al., 2013). In 
addition to being recruited to stress-induced SGs, overexpressed mutant FUS can 
spontaneously form small cytoplasmic granules that coalesce into larger assemblies 
containing SG markers (Kino et al., 2011; Shelkovnikova et al., 2014a). It has been 
proposed that FUS-enriched cytoplasmic assemblies, when they persist, may serve as 
precursors of pathological FUS inclusions in FUS proteinopathies (Bentmann et al., 2013; 
Shelkovnikova et al., 2013b). Conspicuously, FUS-positive inclusions in ALS-FUS contain 
SG marker proteins (Dormann et al., 2010). However, the nature of a stressor (or stressors) 
that can induce sustained presence of FUS-positive assemblies and thereby act as a trigger, 
or “second hit”, in FUS proteinopathies remains experimentally unaddressed. 
Epidemiological and clinical evidence for a connection between viral infection and ALS has 
been accumulating for decades (Celeste and Miller, 2018; Ravits, 2005; Vandenberghe et 
al., 2010). For example, it is known that individuals with a history of poliomyelitis have higher 
risk of developing motor neuron disease later in their lives (Martyn et al., 1988). Similarly, 
patients infected with HIV or human T cell leukemia virus-1 develop neurological disorders 
resembling clinical features of ALS (Alfahad and Nath, 2013). Importantly, multiple viruses 
are able to induce SG assembly (McCormick and Khaperskyy, 2017; White and Lloyd, 
2012). 
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In the current study, we show that the exposure to foreign dsRNA, typical for some viral 
infections, is a potent inducer of persistent FUS-enriched assemblies in the cytoplasm of 
cells expressing either exogenous or endogenous mutant FUS. Furthermore, we show that 
type I interferon, the central component of antiviral signalling, promotes accumulation of FUS 
protein. We propose that the antiviral immune response, with its profound effect on FUS 
levels and distribution, can serve as a trigger of FUS proteinopathy in ALS-FUS. 
 
Results 
Viral dsRNA mimic causes formation of persistent stress granules which recruit 
mutant FUS 
Our initial aim was to identify stressors that can induce prolonged presence of SGs in normal 
(wild-type, WT) human neuroblastoma (SH-SY5Y) cells. In our analysis, we included 
neurodegeneration-relevant stressors: sodium arsenite (SA, oxidative stress), dithiothreitol 
(DTT, endoplasmic reticulum stress), and MG132 (proteasome inhibition). In addition, we 
tested a combination of the HSP70 inhibitor pifithrin-µ and puromycin that is known to induce 
SG formation by simultaneous polysome dissociation and accumulation of misfolded 
proteins (Bounedjah et al., 2014). Viral infection can be a potent SGs inducer, therefore a 
viral dsRNA mimic, synthetic dsRNA polyinosinic:polycytidylic acid (poly(I:C)) was also 
included. It is proposed that repetitive stresses causing multiple cycles of SG assembly-
disassembly might lead to the appearance of persistent SGs (Wolozin, 2012). Stress 
induced by SA, DTT and MG132 is reversible, which also allowed examination of the effect 
of repetitive stresses. The treatment timeline for each stressor is schematically depicted in 
Figure 1A. SGs were visualised by staining for a core SG protein G3BP1. SA, DTT, MG132, 
pifithrin-µ/puromycin and poly(I:C) induced SG assembly in 100%, 95.3±1.8%, 34.7±2.3%, 
30.0±3.6% and 52.4±3.0% cells, respectively (Figure 1B). Two consecutive stresses with 
SA, DTT and MG132, separated by a 24 h recovery period, did not increase SG numbers, 
and the removal of the stressor after first and second rounds of stress led to SG disassembly 
with equal efficiency (Figure 1B). The viral infection mimic was the only stressor whose 
single application induced the assembly of persistent SGs: 24 h and 48 h after poly(I:C) 
transfection, SGs were still detectable in 47.6±3.5% and 27.7±4.0% cells, respectively 
(Figure 1B). Interestingly, we found that poly(I:C) was also able to induce SGs in a fraction of 
hES-derived motor neurons (Figure S1). Given the epidemiological link between viral 
infection and ALS and the ability of multiple viruses to interact with the SG pathway, we 
further focused on this stressor. 
Several stressors are known to cause the formation of FUS-positive SGs in cells expressing 
mutant versions of the protein, including oxidative stress, heat shock, osmotic stress and 
proteasome inhibition (Dormann et al., 2010; Mateju et al., 2017; Sama et al., 2013; 
Shelkovnikova et al., 2014a), however, the effect of viral infection on mutant FUS has not 
been reported. Synthetic dsRNA poly(I:C) is capable of triggering core features of the 
antiviral response upon its delivery into mammalian cells, including SG formation 
(Weissbach and Scadden, 2012). Importantly, the use of poly(I:C) can mimic a response 
typical for multiple types and classes of viruses. In our experiments, we used an 
experimentally defined optimal concentration of poly(I:C) which efficiently and consistently 
induced SGs in SH-SY5Y cells without overt toxicity (Figure S2A).  
We studied mutant FUS recruitment into poly(I:C)-induced SGs in recently generated 
CRISPR/Cas9 cell lines expressing endogenous FUS lacking the NLS, FUSΔNLS (An et al., 
2019) (see STAR Methods). Homozygous (hereafter ΔNLS_ho) and heterozygous (hereafter 
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ΔNLS_het) FUSΔNLS lines are characterised by significant and mild cytoplasmic FUS 
mislocalisation, respectively, and endogenous mutant FUS is efficiently recruited into SA-
induced SGs (An et al., 2019). We found that diffusely distributed cytoplasmic mutant FUS, 
but not WT FUS, was readily recruited into poly(I:C)-induced SGs visualised with antibodies 
against SG marker proteins G3BP1, ATXN2 and YBX1 (Figure 2A; Figure S3A). Poly(I:C)-
induced SGs in FUSΔNLS lines were bona fide SGs since they contained polyadenylated 
RNA (Figure S3B) and were sensitive to cycloheximide (Figure S3C).  
In ΔNLS_het cells, significantly more SGs assembled early after poly(I:C) transfection (2 and 
4 h time-points), and more SGs were still present 24 h post-transfection, as compared to WT 
cells (Figure 2B). In contrast, there was no difference in SG numbers between WT and 
ΔNLS_het cells during the recovery from SA-induced stress (Figure 2B). 
We found that upon poly(I:C) stimulation, neuroblastoma cells usually develop larger, few-
per-cell SGs, as opposed to multiple small- or medium-sized SGs in cells treated with the 
other stressors tested. We quantified the proportion of cells that possess 1, 2 or >2 SGs per 
cell, as well as measured SG area in FUSΔNLS cells subjected to SA for 1.5 h or poly(I:C) 
for 6 h (these stress durations did not significantly affect the morphology/viability of 
neuroblastoma cells, Figure S2C). This analysis revealed that a substantial proportion of 
poly(I:C)-stimulated FUSΔNLS cells contained 1-2 SGs per cell, of larger size, as compared 
to SA-stressed cells which presented with smaller, more numerous SGs (Figure 2C-E). 
Strikingly, large SGs induced by poly(I:C) were able to sequester almost the entire pool of 
FUS in homozygous FUSΔNLS lines, leading to its near-complete nuclear depletion (Figure 
2F). Finally, poly(I:C) was able to induce FUS-positive SGs in human patient fibroblasts 
bearing FUS P525L mutation, which were detectable up to 24 h post-transfection (Figure 
2G). 
Thus, mimicking viral infection by dsRNA delivery can cause prolonged presence of large 
FUS-positive SGs in cells expressing endogenous mutant FUS. 
 
Mimicking viral infection promotes formation of cytoplasmic FUS aggregates 
Previously, we and others showed that exogenously expressed mutant FUS forms 
spontaneous cytoplasmic granules in a fraction of unstressed cells, which we termed “FUS 
granules (FGs)” (Kino et al., 2011; Shelkovnikova et al., 2014a). Consistently, in some of 
FUSΔNLS lines, the endogenous level of mutant FUS was sufficient to support the assembly 
of FGs (lines ΔNLS2_het and ΔNLS11_het, Figure 3A). Similar to those formed by 
overexpressed protein (hereafter, exoFGs), FGs composed of endogenous protein 
(hereafter, endoFGs) were negative for core SG proteins G3BP1 and TIAR (Figure 3B) and 
were sensitive to actinomycin D treatment (Figure S4). 
In SA-stressed cells, exoFGs can coalesce into larger assemblies, referred to as “FUS 
aggregates (FAs)”, which recruit SG proteins (Shelkovnikova et al., 2014a). We found that 
poly(I:C) was also capable of triggering the formation of FAs in cells with endoFGs (Figure 
3C). These endoFAs were readily distinguishable from FUS-positive SGs due to their 
“grainy”, irregularly-shaped appearance as compared to the amorphous, smooth-edged SGs 
formed in endoFG-negative FUSΔNLS lines (Figure 3C). EndoFAs were able to sequester 
G3BP1 and TIAR proteins, however, in contrast to FUS-positive SGs, G3BP1/TIAR signal 
was intermingled with FUS signal forming a patchy pattern within these structures (Figure 
3C). Similar to FUS-containing SGs, endoFAs persisted in FUSΔNLS lines, being still 
detectable in 45.6±2.1% cells 24 h post-transfection (Figure 3D). 
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In order to characterise the dynamics of poly(I:C)-induced FA assembly, we used confocal 
live imaging of cells with exoFGs formed by GFP-tagged FUS bearing R522G mutation. 
Poly(I:C) induced rapid assembly of exoFAs, which grew by clustering, eventually forming 
one or two large aggregates per cell, and such cells remained alive for at least 12 h (Figure 
3E, Video S1). 
To summarise, our data suggest that the presence of endogenous mutant FUS in the 
cytoplasm is sufficient to form spontaneous FUS granules which can become “seeds” for 
larger assemblies, FUS aggregates. Mimicking viral infection promotes formation of FUS 
aggregates composed of such FUS granules, which can persist in cultured cells for hours 
and even days. 
 
Poly(I:C)-induced mutant FUS assemblies sequester nucleocytoplasmic transport 
factors and the autophagy receptor optineurin 
Aggregates composed of mutant FUS have been found to sequester other proteins, such as 
SMN complex factors, P-body and paraspeckle components, presumably leading to their 
loss of function (Groen et al., 2013; Shelkovnikova et al., 2014a; Shelkovnikova et al., 
2014b). Optineurin is the autophagy receptor involved in aggrephagy and encoded by an 
ALS-linked gene, OPTN; it regulates critical processes at the crossroads of autophagy and 
viral infection (Ryan and Tumbarello, 2018). Previously optineurin was identified as a 
component of FUS aggregates in ALS-FUS post-mortem tissue (Ito et al., 2011) however its 
possible recruitment into FUS aggregates in cell models has not been studied. We examined 
optineurin distribution in SA- and poly(I:C)-stressed WT neuroblastoma cells and found that 
this protein was sequestered into both types of SGs (Figure 4A; Figure S5A). Focusing on 
poly(I:C)-induced SGs, we found that in FUSΔNLS lines, SGs recruited significantly more 
optineurin, as compared to WT cells (Figure 4B). Optineurin was also detected in exoFAs 
formed under basal conditions (Figure 4C). In contrast, another ALS-linked protein and 
important optineurin interactor TBK1 (Freischmidt et al., 2015; Wild et al., 2011) was not 
recruited into FUS-containing SGs or into FAs (Figure S5B). Similarly, the principal 
component of autophagy-initiating complexes ULK1 was not detected in SGs (Figure S5B). 
Thus, abnormal optineurin retention in FUS assemblies would sequester it away from 
autophagic complexes which may negatively affect macroautophagy. 
Disrupted nucleocytoplasmic transport has been implicated in multiple ALS subtypes 
(Boeynaems et al., 2016), whereas SGs have been reported to sequester nucleocytoplasmic 
transport factors, including Transportin 1 (TNPO1), the main import receptor for FUS (Zhang 
et al., 2018). We examined whether poly(I:C)-induced mutant FUS assemblies in FUSΔNLS 
cells contain nucleocytoplasmic transport factors TNPO1, Karyopherin Alpha 2 (KNPA2) and 
nucleoporins Nup98 and Nup107 (localised in the inner ring and outer ring of the nuclear 
pore complex, respectively). We found that TNPO1, KNPA2 and Nup107, but not Nup98, 
accumulated within poly(I:C)-induced SGs and endoFAs (Figure 4D; Figure S5C). 
These data indicate that dsRNA-induced mutant FUS assemblies can cause partial depletion 
of optineurin and nucleocytoplasmic transport factors. 
 
Mutant FUS expressing cells are hypersensitive to dsRNA toxicity 
We next asked whether the presence of mutant FUS may result in increased sensitivity to 
dsRNA toxicity. The number of apoptotic cells, as visualised by staining for cleaved caspase 
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3 (CC3), was significantly increased in homozygous FUSΔNLS lines as compared to WT 
cells stimulated with poly(I:C) for 24 h (Figure 5A). FUSΔNLS lines also had elevated mRNA 
levels for the pro-apoptotic factor CHOP (Figure 5B). Furthermore, human patient fibroblasts 
bearing FUS P525L mutation had dramatically increased susceptibility to poly(I:C)-induced 
cell death (Figure 5C). Differences in survival between control and patient fibroblasts were 
apparent already 4 h after poly(I:C) transfection, and quantification of CC3-positive cells 
revealed that significantly more cells were undergoing apoptosis in mutant fibroblast cultures 
8 h post-transfection (Figure 5C). 
We concluded that cells expressing mutant FUS are less competent in handling dsRNA-
induced toxicity. 
 
Type I interferon stimulates accumulation of normal and mutant FUS protein 
In FUS proteinopathy, FUS protein accumulates in the cytoplasm in large quantities, and its 
increased local concentration likely contributes to its aggregation and inclusion formation. 
Since FUS was previously identified as a potent negative regulator of antiviral gene 
expression (Amit et al., 2009), we hypothesised that during antiviral response, cells may 
develop increased demand for FUS protein leading to its upregulation that may contribute to 
FUS proteinopathy development. In line with this prediction, qPCR analysis revealed 
upregulation of FUS mRNA in poly(I:C)-stimulated WT cells (Figure 6A). Type I interferons 
(IFNs) are the principal drivers of gene expression changes in response to dsRNA. Thus, we 
examined whether FUS mRNA upregulation is downstream of IFN signalling. Treatment with 
IFN-beta, the main type I IFN induced by poly(I:C) in SH-SY5Y cells (Shelkovnikova et al., 
2018), increased FUS mRNA levels, with a peak at 4 h, followed by a gradual decline 
(Figure 6B). The increase in FUS mRNA level was more pronounced in IFN-treated as 
compared to poly(I:C)-stimulated cultures, consistent with induction of IFN response only in 
a fraction of cells in poly(I:C)-stimulated cultures due to less than 100% transfection 
efficiency. Consistent with increased mRNA levels, we detected time-dependent 
accumulation of FUS protein in IFN-treated cells (Figure 6C). It should be noted that FUS 
protein did not accumulate in poly(I:C)-treated cells despite upregulated mRNA (Figure 
S6A). This is explained by significant impairment of protein translation in poly(I:C)-
transfected but not in IFN-stimulated cells, as confirmed by puromycin incorporation assay 
(Figure S6B). 
FUS mRNA can be upregulated in IFN-treated cells via a transcriptional mechanism or due 
to its increased stability. We found that FUS pre-mRNA level in treated cultures did not 
increase (Figure 6D). Furthermore, FUS mRNA upregulation induced by IFN-beta was still 
evident in cells upon blocking transcription with actinomycin D or DRB (Figure S6C). STAT1 
is the main transcriptional mediator of IFN-beta signalling, and although the FUS gene 
possesses a STAT1-binding site in its promoter region, the degree of IFN-induced FUS 
mRNA upregulation was not prevented by STAT1 knockdown (Figure S6D). Thus, a 
transcriptional mechanism may not significantly contribute to the effect of IFN-beta on FUS 
mRNA levels. Since mRNA stability is mainly regulated by polyadenylation, we measured 
poly(A) tail (PAT) length of FUS mRNA by a PCR-based PAT assay. We found that IFN-beta 
exposure shifted the intensity of FUS mRNA smear towards longer poly(A) tails (Figure 6E).   
We next examined whether IFN-beta exerted a similar effect on mutant FUS. We found that 
FUS protein levels increased after 24-h IFN-beta treatment not only in WT cells but also in 
FUSΔNLS lines (Figure 6F). Strikingly, both normal and mutant FUS proteins continued to 
accumulate 24 h after removing IFN-beta from the culture medium (Figure S6E). At the 
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same time, in IFN-beta treated cells, subcellular localisation of FUS remained unaffected 
(Figure 6G). It should be noted that IFN treatment alone did not induce SGs in mutant FUS-
expressing cells, consistent with previous findings (John and Samuel, 2014) and with a 
limited effect of IFN on protein translation (Figure S6B). FUS mRNA levels are known to be 
subject to autoregulation, where FUS protein binds its own transcript and promotes 
production of an unstable isoform lacking exon 7; autoregulation ability of mutant FUS is 
impaired (Zhou et al., 2013). Consistent with defective autoregulation of FUS mutants, 
FUSΔNLS cells failed to upregulate the exon7-skipped (ex7-) FUS isoform during IFN 
treatment (Figure 6H). 
Overall, our data indicate that type I IFN, the main component of antiviral signalling, can 
drive accumulation of mutant FUS protein. 
 
Infection with an RNA virus induces FUS pathology in mutant FUS expressing cells  
To corroborate the data obtained with a viral infection mimic, we next investigated changes 
in mutant FUS distribution in response to an RNA virus infection. Respiratory syncytial virus 
(RSV) possesses a negative-sense RNA genome which gives rise to a dsRNA intermediate 
in its life cycle; it is capable of maintaining prolonged stress response accompanied by SG 
assembly (Groskreutz et al., 2010; Lindquist et al., 2010). Inoculation of WT SH-SY5Y cells 
with RSV strain A2 led to the appearance of cell clusters with altered cellular morphology, 
including nuclear swelling and presence of SGs, 24 h post-infection (Figure 7A). Infected 
cultures also displayed upregulation of viral infection markers IFN-beta, IFIT3 and CXCL10 
(Figure 7B). We next inoculated WT and FUSΔNLS lines and analysed them 8, 24 and 48 h 
post-infection. Similar to poly(I:C)-stimulated cells, FG-negative FUSΔNLS lines developed 
large FUS-positive SGs, whereas a FG-positive line (ΔNLS11_het) developed endoFAs 24 h 
post-infection (Figure 7C). At this time point, the proportion of SG-positive cells was higher in 
FUSΔNLS cultures as compared to WT cells (Figure 7D). Prolonged RSV infection was toxic 
for neuroblastoma cells, leading to significant cell death 48 h post-infection, which was more 
pronounced in FUSΔNLS lines (Figure 7E). FUS-positive SGs were still detectable in some 
cells at this stage (Figure 7E, insets). RSV infection was also capable of inducing FUS-
positive SGs in FUS P525L human patient fibroblasts (Figure 7F). Consistent with poly(I:C) 
and IFN data (Figure 6), infected WT and FUSΔNLS cells both presented with FUS mRNA 
upregulation (Figure 7G). Finally, RSV-induced mutant FUS assemblies sequestered 
optineurin, TNPO1 and Nup107 (Figure 7H). 
Overall, core features of FUS pathology triggered by a synthetic dsRNA were observed after 
infection with a SG-inducing virus. 
 
Discussion 
In FUS proteinopathies, cytoplasmic accumulation of FUS can be dramatic, leading to the 
formation of large inclusions sometimes filling up the entire cytosolic space (Deng et al., 
2010). Yet even overexpression of ALS-linked FUS mutants in the mammalian CNS is not 
sufficient to cause overt FUS deposition and proteinopathy. Based on our data, we propose 
a model whereby a viral infection involving dsRNA response can serve as a trigger, or 
“second hit”, for FUS proteinopathy in humans. It does so by causing (cytoplasmic) FUS 
accumulation, formation of persistent FUS-enriched cytoplasmic assemblies and impaired 
aggrephagy. The nature of the “third hit”, which would facilitate the converstion of dynamic 
FUS-positive assemblies into stable proteinaceous inclusions remains unclear. However, 
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one can speculate that viral manipulation of the host RNA levels may be a contributory 
factor. Indeed, viral infections are often associated with attenuated host gene transcription 
and RNase L-mediated cleavage of cellular RNAs (Abernathy and Glaunsinger, 2015), 
whereas we and others showed that RNA binding protects FUS from irreversible aggregation 
(Maharana et al., 2018; Shelkovnikova et al., 2014a). The existence of an additional factor(s) 
triggering FUS proteinopathy is consistent with the recently proposed “multistep model” for 
ALS development, where intrinsic and extrinsic risk factors interact to realise the genetic 
predisposition and initiate the pathological process (Al-Chalabi et al., 2014). Considering that 
ALS is a six-step process and that mutations do decrease the number of steps, two or three 
steps will still be necessary for the development of the disease (Chio et al., 2018). 
Several stresses, including those implicated in neurodegeneration, such as proteasomal 
dysfunction, oxidative stress and ER stress, are known to cause formation of FUS-positive 
assemblies in cultured cells including neurons (Ederle and Dormann, 2017). However, such 
assemblies are unstable and readily dissipate when stress is resolved. Moreover, all of these 
stressors cause an acute response, which, if not resolved after a short period of time 
(usually up to several hours), kills the cell. In most instances, SGs eventually disassemble to 
allow restoration of translation, even if the stress persists (Shelkovnikova et al., 2017). SG-
inducing viral infections are principally different in this regard, because they result in 
prolonged and, in some cases, oscillating SG response, which allows phases of active and 
stalled translation and ensures cell survival (Ruggieri et al., 2012). Thus, antiviral response 
may initiate/promote FUS proteinopathy in neurons and glia while keeping these cells alive 
for a period of time long enough to allow FUS inclusion formation. 
Here, we refer to FUS aggregates (FAs) composed of spontaneous FUS granules (FGs) and 
FUS-positive SGs as “mutant FUS-containing cytoplasmic assemblies”. The ability of mutant 
FUS to assemble into FGs under basal conditions and subsequently into FAs under 
conditions of stress in cultured cells, including neurons, has been confirmed by us as well as 
by several other groups (Japtok et al., 2015; Kino et al., 2011; Lenzi et al., 2015; 
Shelkovnikova et al., 2014a). Regardless of the relative contribution of FUS-positive SGs 
and FAs to the disease pathogenesis, in the current study, we have shown that antiviral 
signalling can promote formation and persistence of both types of assemblies. 
Compromised autophagic clearance has been heavily implicated in the proteinopathy 
development in different ALS subtypes (Weishaupt et al., 2016). Previously, mislocalised 
FUS has been shown to negatively affect autophagic protein clearance, which can contribute 
to FUS proteinopathy development (Ryu et al., 2014; Soo et al., 2015). Our findings 
corroborate the histopathological data (Ito et al., 2011) on possible loss of function of 
optineurin and hence impairment of aggrephagy in ALS-FUS. Autophagy is known to 
function in the control of viral replication and to exert other antiviral effects; many viruses 
have evolved mechanisms to inhibit autophagy at different levels (Lee and Iwasaki, 2008). 
Therefore, a viral infection could exacerbate pre-existing defects in autophagy in mutant 
FUS expressing cells. 
Available data suggest that even subtle changes in FUS levels can trigger motor neuron 
pathology. Indeed, ALS-causative mutations in the FUS 3’UTR, which cause increased 
protein levels, have been described (Sabatelli et al., 2013). In the current study, we report 
the ability of a physiologically relevant molecule, type I IFN, to trigger accumulation of FUS 
protein. In addition, although IFN per se does not induce SG assembly, it can potentiate SG 
formation in infected cells (John and Samuel, 2014; Ruggieri et al., 2012). Type I IFN 
induction is not limited to viral infection and can be caused by other immune stimuli, 
however, only during antiviral signalling, sustained IFN expression is observed (Amit et al., 
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2009). Both neurons and glia express IFNs and their receptors (Chhatbar et al., 2018). 
Interestingly, we found that one of the two IFN receptor subunits, IFNAR1, is highly 
expressed specifically in ventral horn neurons of the spinal cord and that it is depleted from 
the spinal cord of ALS-FUS patients (Figure S7). Since IFNAR1 undergoes ligand-
dependent degradation during viral infection (de Weerd and Nguyen, 2012), this finding is 
consistent with the idea that sustained antiviral signalling might take place in the nervous 
system of ALS-FUS patients. 
Intriguingly, viral infections are known to promote formation of another type of RNA granule, 
paraspeckles (Imamura et al., 2014), whereas spinal neurons in ALS, including ALS-FUS, 
are characterised by paraspeckle hyper-assembly (An et al., 2019; Nishimoto et al., 2013; 
Shelkovnikova et al., 2018). Activation of paraspeckle signalling in the ALS spinal cord 
provides yet another evidence in support to the hypothesis of activated antiviral response in 
this disease. 
The model proposed here is fully applicable for ALS-FUS, however, for FTLD-FUS cases, 
which usually do not involve FUS mutations, additional factors are required to cause nuclear 
import defect. However, such defect might be caused by viral subversion of the nuclear pore 
complex (NPC). Viruses are known to hijack NPC components and other factors to enable 
trafficking of viral proteins (Le Sage and Mouland, 2013). Furthermore, some viral proteins 
have a high affinity to TNPO1. For example, enterovirus and cardiovirus infections alter NPC 
composition to relocalise some nuclear proteins to the cytoplasm, whereas enteroviruses are 
known to induce degradation of nucleoporins Nup62, Nup98 and Nup153 (Hindley et al., 
2007). A combination of a viral infection and the presence of persistent FUS assemblies that 
sequester NPC components can have an additive negative effect on nucleocytoplasmic 
transport. 
In addition to the existence of an epidemiological link between viral infections and ALS 
(Ravits, 2005; Vandenberghe et al., 2010), a number of viruses are known to cause cellular 
and molecular phenotypes typical for ALS. For example, enteroviral and encephalomyelitis 
infections result in cytoplasmic aggregation of TDP-43 in vivo, in the murine CNS (Masaki et 
al., 2019; Xue et al., 2018). Notably, enteroviruses (including poliovirus) possess a dsRNA 
intermediate in their life cycle that triggers SG formation (Lloyd, 2016). Incomplete and non-
penetrance is common for FUS mutations, with the age of onset varying from early 20s to 
late 70s even within the same family (Mackenzie et al., 2010). Thus, one can speculate that 
common viral infections can trigger the disease, which otherwise would not manifest, by 
further dysregulating cellular pathways already perturbed in individuals genetically 
predisposed to develop ALS. 
In conclusion, our study provides a framework for investigating the role of the antiviral 
signalling in FUS proteinopathies. Further studies are needed to establish whether viral 
infection would be sufficient to induce formation of FUS inclusions in motor neurons derived 
from ALS-FUS patient iPSCs and, most interestingly, in the available rodent models of FUS 
pathology. 
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Figure Legends 
Figure 1. Viral dsRNA mimic triggers formation of persistent stress granules. 
(A)Timelines for the experiments to study SG persistence in SH-SY5Y cells. Time-points for 
treatments/transfection, wash-off and cell collection are indicated by red, blue and pink 
arrowheads, respectively. 
(B) Representative images and quantification of SG-containing cells after stress and 
recovery. Percentage of SG-positive cells at each time-point is indicated on the scatter plots. 
X-axis labelling (1-4) corresponds to the column labelling (1st stress, 1st recovery, 2nd stress, 
2nd recovery). SGs were visualised using anti-G3BP1 staining. Between 250 and 300 cells 
were analysed per each stressor/time-point. N/A, not available – single application of 
poly(I:C) was used. Data are represented as mean±SEM; mean percentages of cells with 
SGs are also indicated on the scatter plots. Scale bar, 10 µm. 
 
Figure 2. Mutant FUS is recruited to poly(I:C)-induced stress granules. 
(A) Endogenous mutant FUS is highly enriched in poly(I:C)-induced SGs in FUSΔNLS lines. 
Cells were analysed 4 h after poly(I:C) transfection. Representative images for two 
heterozygous (ΔNLS_het) and two homozygous (ΔNLS_ho) lines are shown.  
(B) Poly(I:C) but not sodium arsenite (SA) causes persistent SGs in mutant FUS expressing 
cells. Quantification of cells containing SGs in ΔNLS_het lines (two lines combined) and WT 
cells over a 24 h follow-up period post-transfection/treatment is shown. Cells were treated 
with SA for 1 h, washed and analysed during recovery. ≥500 cells were analysed per 
line/time-point. *p<0.05; **p<0.01; ***p<0.001 (Student’s t-test). 
(C-E) Poly(I:C) induces a few large SGs per cell in FUSΔNLS lines. Representative images 
(C) as well as quantification of SG area (D) and the fraction of cells containing 1, 2 and >2 
SG (E) in FUS∆NLS cells are shown. In D and E, data for two ΔNLS_het and two ΔNLS_ho 
lines were combined. Between 250 and 400 cells were analysed in D, and between 92 and 
141 cells – in E. ****p<0.0001 (Student’s t-test). 
(F) Near-complete clearance of mutant FUS from the nucleus in poly(I:C)-stimulated but not 
SA-treated ΔNLS_ho cells. Nuclei are circled. Note loss of nuclear FUS in two SG-containing 
cells in the poly(I:C)-stimulated culture (nuclei circled in blue). 
(G) Poly(I:C) induces FUS-positive SGs in human patient fibroblasts bearing P525L 
mutation. Fibroblasts were analysed 24 h post-transfection. Fibroblasts treated with SA for 1 
h are shown for comparison. 
In C-F, cells were analysed 6 h after poly(I:C) transfection and 1.5 h after SA addition. In B 
and D, data are represented as mean±SEM. 
Scale bars, 10 µm. 
 
Figure 3. Mimicking viral infection promotes formation of cytoplasmic FUS 
aggregates. 
(A) Spontaneous granules formed by endogenous mutant FUS protein (endoFGs) are 
present in the cytoplasm of two ΔNLS_het lines under basal conditions. 
(B) SG markers G3BP1 and TIAR are absent from endoFGs. 
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(C) Non-overlapping localisation of mutant FUS and SG proteins in endoFUS aggregates 
(endoFAs) formed in a FG-positive cell line (ΔNLS11_het) after poly(I:C) transfection. 
Images of FUS-positive SGs formed in a FG-negative line (ΔNLS10_het) are shown for 
comparison. Cells were analysed 4 h post-transfection.  
(D) Quantification of the number of cells containing endoFAs in ΔNLS_het lines (data for two 
lines combined) over a 24-h period post-transfection. ≥500 cells were analysed per line/time-
point. Data are represented as mean±SEM. 
(E) Formation of exoFAs in response to poly(I:C). WT cells were transfected with a FUS 
R522G GFP expression vector; 24 h after, cells were transfected with poly(I:C), and two 
cells with preformed exoFGs were followed up for 12 h using time-lapse confocal imaging. 
Two aggregates that eventually fuse to form one large aggregate are indicated with 
arrowheads. Also see Video S1. 
In A-C, representative confocal images (single optical section) are shown. 
Scale bars, 10 μm. 
 
Figure 4. Optineurin and nucleocytoplasmic transport factors are recruited into 
mutant FUS assemblies. 
(A) Optineurin is a component of poly(I:C)-induced SGs in WT cells. Cells were analysed 6 h 
post-transfection. 
(B) More optineurin is retained in poly(I:C)-induced SGs in FUSΔNLS lines as compared to 
WT cells. Arrowheads indicate optineurin-positive SGs in WT cells. Cells were analysed 24 h 
post-transfection. Graph shows optineurin staining intensity in SGs (n≥30). ***p<0.001, 
****p<0.0001 (one-way ANOVA with Dunnett’s test). Data are represented as mean±SEM. 
(C) FUS aggregates (FAs) formed by overexpressed GFP-tagged FUS R522G sequester 
optineurin under basal conditions. 
(D) Nucleocytoplasmic transport factors Nup107, KPNA2 and TNPO1 are recruited into 
mutant FUS cytoplasmic assemblies in poly(I:C)-stimulated FUSΔNLS cells. Note that 
∆NLS11_het cell line contains endoFGs and therefore forms FAs not SGs. Cells were 
analysed 6 h post-transfection. 
Scale bars, 10 μm. 
 
Figure 5. Cells expressing mutant FUS are hypersensitive to dsRNA toxicity. 
(A) Increased number of cleaved caspase 3 (CC3) positive cells in poly(I:C)-stimulated 
ΔNLS_ho cultures. Cells were analysed 24 h post-transfection. Data for two ΔNLS_het and 
two ΔNLS_ho lines were combined for the graph. 7 fields of view (x20 magnification) were 
included into analysis per line. *p<0.05 (one-way ANOVA with Dunnett’s test). 
Representative images are also shown. Scale bar, 50 μm. 
(B) Elevated levels of the proapoptotic factor CHOP in FUSΔNLS lines after poly(I:C) 
stimulation. Cells were analysed by qRT-PCR 24 h post-transfection. Combined data for 
three ΔNLS_het and three ΔNLS_ho lines are shown (n=3 for each line). *p<0.05 (Mann-
Whitney U test). 
(C) Mutant FUS P525L fibroblasts are more sensitive to poly(I:C) as compared to control 
fibroblasts. Representative images and quantification of CC3-positive cells 8 h post-
transfection are shown. 9 and 12 fields (x20 magnification) were included into analysis for 
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control and P525L fibroblasts, respectively. Arrowheads indicate CC3-positive cells. ****-
p<0.0001 (Student’s t-test). Scale bars, 50 μm and 10 μm for bright field images and 
fluorescent images, respectively. 
In all panels, data are represented as mean±SEM. 
 
Figure 6. Type I interferon promotes accumulation of normal and mutant FUS protein  
(A) FUS mRNA level is increased in poly(I:C)-stimulated WT SH-SY5Y cells 24 h post-
transfection as measured by qRT-PCR. N=4, *p<0.05 (Mann-Whitney U test). 
(B) IFN-beta treatment alone upregulates FUS mRNA in WT cells. FUS mRNA levels in IFN-
beta treated cells were measured by qRT-PCR at the indicated time points. N=4-5. *p<0.05; 
**p<0.01; ***p<0.001 (Mann-Whitney U test). 
(C) IFN-beta treatment causes FUS protein accumulation in WT cells in a time-dependent 
manner. Representative Western blot and quantification of FUS protein levels after 24 h of 
IFN-beta treatment are shown. Western blot also demonstrates degradation of the IFNAR 
receptor subunit in IFN-treated cells. N=3, *p<0.05 (Mann-Whitney U test). 
(D) FUS pre-mRNA is not upregulated during IFN-beta treatment. Two pairs of primers 
mapping to the intron sequences of the FUS gene were used for qRT-PCR. N=3. 
(E) FUS mRNA species with longer poly(A) tails accumulate in cells treated with IFN-beta as 
revealed by the poly(A)-tail (PAT) assay. Diagram shows the principle of PAT assay. P1, P2 
and P3 are FUS-specific forward, FUS-specific reverse and universal reverse primers 
respectively. ‘PA’ stands for poly(A) tail (amplified with P1 and P3 primers) and ‘int’ – for the 
internal FUS fragment (amplified with P1 and P2 primers). Electrophoresis image 
demonstrates similar band intensity for the internal FUS fragment but increased intensity of 
the smear corresponding to the longer poly(A) tails; intensity profile of the PA lanes is also 
shown. Cells were treated with IFN-beta for 8 h. 
(F) Mutant FUS protein accumulates in FUSΔNLS cells upon IFN-beta treatment. Cells were 
treated with IFN-beta for 24 h. FUS knockout line was included as a negative control. 
(G) IFN-beta treatment does not alter the subcellular localisation of normal and mutant FUS. 
Cells were treated with IFN-beta for 24 h. Scale bar, 10 μm. 
(H) Levels of exon7-skipped FUS mRNA transcript (FUS ex7-) significantly increase in WT 
but not in FUSΔNLS lines upon IFN-beta exposure. Cells were treated with IFN-beta for 24 h 
and analysed by qRT-PCR. N=4, *p<0.05 (Mann-Whitney U test). 
In all panels, data are represented as mean±SEM. 
 
Figure 7. Infection with respiratory syncytial virus (RSV) induces cytoplasmic FUS 
assemblies and is toxic in mutant FUS expressing cells. 
(A) RSV infection of SH-SY5Y cells leads to the appearance of clusters of cells with swollen 
nuclei and cytoplasmic SGs. Representative images of WT cells 24 h post-infection are 
shown.  
(B) Upregulation of antiviral markers in RSV-infected WT cells as analysed by qRT-PCR. 
N=4, ****p<0.0001 (Student’s t-test). 
(C) RSV-inoculated cells develop FUS-positive SGs (ΔNLS4_ho and ΔNLS10_het lines) and 
FAs (ΔNLS11_het line). Cells were analysed 24 h post-infection. 
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(D) More cells develop SGs in FUSΔNLS cultures as compared to WT cells upon RSV 
infection. Proportion of SG-containing cells was quantified 24 h after infection. *p<0.05, 
****p<0.0001 (one-way ANOVA with Dunnett’s test). 
(E) RSV infection is more toxic for FUSΔNLS lines as compared to WT cells. Equal numbers 
of cells were seeded on coverslips and fixed for analysis at the indicated time-points. Note 
that FUS-positive SGs are still detectable in RSV-infected FUSΔNLS lines 48 h post-
infection (insets). 
(F) RSV-infected human patient fibroblasts bearing P525L mutation develop FUS-positive 
SGs 24 h post-inoculation. 
(G) FUS mRNA is upregulated in WT and FUSΔNLS cells in response to RSV infection. FUS 
expression was analysed by qRT-PCR 24 h post-inoculation. N=4, *p<0.05 (Student’s t-test).        
(H) Mutant FUS assemblies contain optineurin and nucleocytoplasmic transport factors 
TNPO1 and Nup107. Cells were fixed and stained 24 h post-inoculation. 
In all panels, cells were infected with RSV strain A2 at MOI of 10 and analysed at the 
indicated time points. In panels B, D, G, data are represented as mean±SEM.  In A, C, E, F, 
H, representative images are shown. Scale bars, A – 50 μm, C, F, H – 10 µm, E – 100 µm.  
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STAR Methods 
Lead Contact and Materials Availability 
Further information and requests for resources and reagents should be directed to and will 
be fulfilled by the Lead Contact, Tatyana Shelkovnikova (shelkovnikovat@cardiff.ac.uk). All 
reagents generated in this study are available from the Lead Contact and may require a 
completed Materials Transfer Agreement. 
Experimental Model and Subject Details 
Cell lines 
Parental SH-SY5Y human neuroblastoma cell line (originating from a 4-year old female) was 
obtained from Sigma (94030304). Generation and characterisation of FUSΔNLS SH-SY5Y 
cell lines has been described in earlier (An et al., 2019). Human fibroblasts acquisition was 
approved by the University of Palermo Review Board (prot.07/2017). Characterisation of 
fibroblasts from a female patient with FUS P525L mutation was described earlier (Chio et al., 
2009; Lo Bello et al., 2017). SH-SY5Y cells and human fibroblasts were grown in high-
glucose 1:1 mixture of DMEM/F12 supplemented with 10% fetal bovine serum (FBS), 1% 
penicillin-streptomycin and 2 mM L-glutamine (all Invitrogen). Human motor neuron 
differentiation from ES cells (H9 line, female) is described in a previous study 
(Shelkovnikova et al., 2017). 
Virus strain 
RSV wild-type strain A2 (18287232) was used at the multiplicity of infection (MOI) of 10 for 
infecting neuroblastoma cells and human fibroblasts. Inoculation was performed in normal 
culturing medium. 
Human post-mortem tissue 
Human samples from clinically and histopathologically characterised ALS cases and healthy 
individuals were obtained from the Sheffield Brain Tissue Bank and MRC London 
Neurodegenerative Diseases Brain Bank. Consent was obtained from all subjects for 
autopsy, histopathological assessment and research were performed in accordance with 
local and national Ethics Committee approved donation. Four ALS-FUS patients were 
included in the study: male (R521C mutation); female (R521C mutation); male (R524T 
mutation); and male (G507N mutation). Immunohistochemistry analysis was performed as 
described earlier (Shelkovnikova et al., 2014b). 
Method details 
Cell transfection and treatments 
Transfections were performed with 200 ng plasmid DNA, 250 ng poly(I:C) (Sigma) or siRNA 
in 24-well plates using Lipofectamine 2000 (Invitrogen). hES cell derived motor neurons 
were transfected with 1 µg poly(I:C) using FuGENE® HD reagent (Promega). Final 
concentrations of compounds were as follows: 0.5 mM sodium arsenite (Sigma), 1 mM DTT 
(Sigma), 50 μM MG132 (Calbiochem), 10 μg/ml puromycin (Sigma), 5 μM pifithrin-μ (Enzo 
Life Sciences), 10 µg/ml cycloheximide (Sigma), 5 µg/ml actinomycin D (Sigma) and 25 
µg/ml DRB (Sigma). Cells were treated with 1x104 IU Interferon beta-1a (Sigma) for the 
indicated periods of time.  
Immunocytochemistry, light and confocal microscopy 
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Cells grown on coverslips were fixed in 4% paraformaldehyde and permeabilised with 
methanol. Primary antibodies diluted in blocking buffer (5% goat serum in 0.1% Tween-
20/PBS) were added on cells for 1 h at RT or overnight at 4°C. Secondary antibodies in 
0.1% Tween-20/PBS (Alexa488- or Alexa546-conjugated, Invitrogen) were applied for 1 h at 
RT. DAPI was used to visualise nuclei. To detect poly(A)+ mRNA, cells were incubated at 
37°C with 1 μM Cy5-labelled oligo(dT)30 probe (Sigma) diluted in hybridization buffer (2x 
SSC, 25 % formamide) overnight, followed by anti-G3BP1 immunostaining. Fluorescent 
images were obtained using BX61 microscope equipped with F-View II camera and CellF 
software (all Olympus). Confocal fluorescent images were taken using LSM880 microscope 
with ZEN software (Zeiss). Plot Profile and 3D Surface Plot functions of Image J were used 
to create profile/surface plots of protein colocalisation. Bright-field images of human 
fibroblasts were taken using EVOS XL Core system. Quantification of stress granules and 
cleaved caspase 3 positive cells was performed using ‘Analyze particles’ function of Image J 
software. Images were assembled using Photoshop CS3. For live imaging of FUS aggregate 
assembly, SH-SY5Y cells were cultured on glass-bottomed culture dishes (Mattek) and 
transfected with a plasmid for the expression of GFP-tagged FUS R522G. After 24 h, cells 
were transfected with poly(I:C) and maintained in HEPES-buffered medium during imaging. 
Imaging was carried out using a Leica TCS SP2 MP confocal microscope (Fluotar L 63 × 1.4 
oil objective) equipped with an on-scope incubator with temperature control (Leica 
Microsystems). A sequence of images taken with 7 min intervals was subsequently 
converted into a movie using Leica Application Suite AF software. 
RNA extraction, qRT-PCR and poly(A)-tail (PAT) length assay 
Total RNA was extracted from cells using GenElute™ Total RNA Purification Kit (Sigma) and 
possible DNA contamination was eliminated with RNase free DNase kit (Qiagen). Total RNA 
(500 ng) was used for first-strand cDNA synthesis with Superscript IV (Invitrogen). qPCR 
was performed on StepOne Plus™ RT-PCR System using DreamTaq HS polymerase 
(Thermo Scientific), and gene expression was normalised to that of GAPDH. Poly(A)-tail 
length assay was carried out using USB® Poly(A) Tail-Length Assay Kit (Thermo Scientific) 
as instructed. PCR products were resolved on 3% agarose gel and lane intensity was plotted 
in arbitrary units using Plot Profile function of Image J. 
Western blotting 
Cell were lysed on plates in 2xLaemmli buffer and the lysates were boiled at 100°C for 5 
min. Proteins were separated on 10% SDS-PAGE and transferred to PVDF membranes 
followed by incubation in 4% skimmed milk for 1 h and in primary antibodies (1:1,000) at 4°C 
overnight. HRP-conjugated secondary antibodies (1:3,000, Amersham) were applied at RT 
for 1.5 h. ECL solution (Advansta) was used for chemiluminescent detection. Western blots 
were re-probed for β-actin as a control for equal loading. Protein labelling with puromycin 
was performed as described earlier (Shelkovnikova et al., 2017). 
Quantification and Statistical Analysis 
Statistical analysis was carried out using GraphPad Prism 6 software. Mean values of 
biological replicates were compared using appropriate tests (stated in the figure legends). 
Significance levels are indicated with asterisks (*p < 0.05, **p < 0.01, ***p < 0.001, 
****p<0.0001). N indicates the number of biological replicates. Error bars represent standard 
error of the mean (SEM). 
Data and Code Availability 
This study did not generate any unique datasets or codes. 
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Video S1. Related to Figure 3. Formation of exoFAs in response to poly(I:C). WT SH-SY5Y 
cells were transfected with a FUS R522G GFP expression vector; 24 h after, cells were 
transfected with poly(I:C), and two cells with preformed exoFGs were followed up using time-
lapse confocal imaging.  
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